Oculis Holding AG
F:CR5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oculis Holding AG
F:CR5
|
CH |
|
E
|
Emerita Resources Corp
F:LLJA
|
CA |
|
A
|
Analog Devices Inc
XMUN:ANL
|
US |
|
Ke Holdings Inc
F:KE8
|
CN |
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
|
P
|
Pro Medicus Ltd
F:PMC
|
AU |
|
E
|
Essex Property Trust Inc
F:EXP
|
US |
|
G
|
Givaudan SA
XBER:GIN
|
CH |
Shareholder Yield
Current shareholder yield for CR5 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CR5 Price
Oculis Holding AG
| Average Annual Return | 8.12% |
| Standard Deviation of Annual Returns | 2.68% |
| Max Drawdown | -69% |
| Market Capitalization | 791m EUR |
| Shares Outstanding | 46 440 000 |
| Percentage of Shares Shorted |
N/A
|
